MD is a consultant for Abbott, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, GI Dynamics, Merck Sharp and Dohme, Novo Nordisk, Poxel Pharma, and Sanoﬁ  ; and is a speaker for AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Novo Nordisk, and Sanoﬁ  . Through MD, the VU University Medical Center received research grants from Abbott, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, Medtronic, Merck Sharp and Dohme, Novo Nordisk, and Sanoﬁ  . MD reports receiving no personal payments for consultancies and speaking, with all payments directly transferred to the Diabetes Centre non-proﬁ  t research foundation. LVG has been paid to serve on advisory panels for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Novo Nordisk, and Sanoﬁ  -Aventis; and has received honoraria as a member of the speaker’s bureau for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly